124 related articles for article (PubMed ID: 1969307)
1. Collection, cryopreservation and autologous transplantation with circulating hemopoietic stem cells in patients with multiple myeloma and lymphoma.
Adam M; Benbunan M; Fermand JP; Gisselbrecht C; Sitthy X; Maréchal B; Marchix T; Gerota J
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():33-4. PubMed ID: 1969307
[No Abstract] [Full Text] [Related]
2. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
3. Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Gastineau DA; Tefferi A; Chen MG; Witzig TE; Greipp PR; Litzow MR
Bone Marrow Transplant; 2000 Jul; 26(1):45-50. PubMed ID: 10918404
[TBL] [Abstract][Full Text] [Related]
4. Unequal results of collection of peripheral blood stem cells in view of autografting in high risk multiple myeloma.
Eisenmann JC; Hénon P; Wunder E; Lepers M; Beck-Wirth G; Debecker A; Prévot G
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():56-7. PubMed ID: 1969316
[No Abstract] [Full Text] [Related]
5. The effects of various chemotherapy regimes on the levels of peripheral blood stem cells in patients with lymphoma.
Craig JI; Parker AC; Anthony RS
Bone Marrow Transplant; 1990 Jan; 5 Suppl 1():30-1. PubMed ID: 1969305
[No Abstract] [Full Text] [Related]
6. Conditions for optimal cryopreservation of peripheral stem cells.
Slaper-Cortenbach IC; Wijngaarden-du Bois MJ; de Vries-van Rossen A; Vos A; Zadurian A
Prog Clin Biol Res; 1994; 389():649-56. PubMed ID: 7700932
[No Abstract] [Full Text] [Related]
7. [Collection and transplantation of hematopoietic stem cells of circulating blood].
Körbling M; Fehrentz D; Rother K; Hunstein W
Beitr Infusionsther; 1988; 21():322-34. PubMed ID: 2463003
[No Abstract] [Full Text] [Related]
8. Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients.
Vescio RA; Wu CH; Zheng L; Sheen D; Ma H; Liu J; Stewart AK; Ballester O; Noga SJ; Rugo H; Freytes C; Stadtmauer E; Sahebi F; Tarantolo S; Stiff P; Schiller GJ; White M; Jacobs C; DiPersio J; Anderson KC; Berenson JR
Bone Marrow Transplant; 2000 Jan; 25(2):153-60. PubMed ID: 10673673
[TBL] [Abstract][Full Text] [Related]
9. First and second apheresis in patients with multiple myeloma: no differences in tumor load and hematopoietic stem cell yield.
Kiel K; Cremer FW; Ehrbrecht E; Wallmeier M; Hegenbart U; Goldschmidt H; Moos M
Bone Marrow Transplant; 1998 Jun; 21(11):1109-15. PubMed ID: 9645573
[TBL] [Abstract][Full Text] [Related]
10. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
[TBL] [Abstract][Full Text] [Related]
11. Collection and use of circulating hematopoietic progenitor cells.
Lee JH; Klein HG
Hematol Oncol Clin North Am; 1995 Feb; 9(1):1-22. PubMed ID: 7737936
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
Callera F; Cavenaghi L; de Melo CM
Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma.
Pileri A; Tarella C; Bregni M; Boccadoro M; Siena S; Caracciolo D; Bonadonna G; Gianni AM
Haematologica; 1990; 75 Suppl 1():79-82. PubMed ID: 1972134
[TBL] [Abstract][Full Text] [Related]
14. CD34+ selection of autologous peripheral blood stem cells for transplantation following sequential cycles of high-dose therapy and mobilization in multiple myeloma.
Dyson PG; Horvath N; Joshua D; Barrow L; Van Holst NG; Brown R; Gibson J; To LB
Bone Marrow Transplant; 2000 Jun; 25(11):1175-84. PubMed ID: 10849530
[TBL] [Abstract][Full Text] [Related]
15. Mobilization, collection, and transplantation of peripheral blood hematopoietic progenitor cells in a patient with multiple myeloma and hemoglobin SC disease.
Tormey CA; Snyder EL; Cooper DL
Transfusion; 2008 Sep; 48(9):1930-3. PubMed ID: 18513256
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood stem cell collection in multiple myeloma: a retrospective analysis of 6 years leukapheresis activity in 109 patients treated at the Istituto Nazionale dei Tumori of Milan.
Coluccia P; Montefusco V; Tunesi S; Avella M; Bompadre A; Longoni P; Milanesi M; De Carli A; Ravagnani F
J Clin Apher; 2009; 24(4):134-40. PubMed ID: 19591198
[TBL] [Abstract][Full Text] [Related]
17. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
18. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use.
Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F
Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176
[TBL] [Abstract][Full Text] [Related]
19. Dose-intensified therapy combined with autologous blood stem cell support in patients with multiple myeloma.
Serke S; Kirsch A; Huhn D
Semin Oncol; 1994 Dec; 21(6 Suppl 16):29-32. PubMed ID: 7528448
[No Abstract] [Full Text] [Related]
20. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg.
Abrahamsen JF; Wentzel-Larsen T; Bruserud O
Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
